ASHLAND INC (ASH)
(Delayed Data from NYSE)
$84.82 USD
+0.25 (0.30%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $84.83 +0.01 (0.01%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$84.82 USD
+0.25 (0.30%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $84.83 +0.01 (0.01%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth D Momentum B VGM
Zacks News
Ashland (ASH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Axalta Coating Systems (AXTA) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 15.69% and 0.45%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Ashland Boosts the Application of Super Wetting Technology
by Zacks Equity Research
ASH's technology enables agricultural retailers to increase crop yield, facilitating organic growth.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ashland Wraps Up Nutraceuticals Business Sale to Turnspire Affiliate
by Zacks Equity Research
ASH's nutraceuticals business provides nutrition product producers with a diverse selection of active ingredients and formulation aids.
Here's Why Ashland (ASH) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ArcelorMittal (MT) Closes Strategic 28% Stake Buy in Vallourec
by Zacks Equity Research
ArcelorMittal (MT) acquires a 28.4% stake in Vallourec, emphasizing its strategic alignment with growth in clean energy markets and bolstering its investment portfolio.
ASH vs. NVZMY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ASH vs. NVZMY: Which Stock Is the Better Value Option?
Why Ashland (ASH) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Ashland's (ASH) Earnings Beat Estimates in Q3, Sales Lag
by Zacks Equity Research
Ashland's (ASH) Q3 sales are adversely impacted by reduced Life Sciences volumes and weaker pricing.
Here's What Key Metrics Tell Us About Ashland (ASH) Q3 Earnings
by Zacks Equity Research
Although the revenue and EPS for Ashland (ASH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ashland (ASH) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 1.36% and 4.40%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Chemours (CC) Earnings Miss, Revenues Beat Estimates in Q2
by Zacks Equity Research
Chemours' (CC) earnings miss estimates in the second quarter due to lower selling prices.
Are Basic Materials Stocks Lagging ASHLAND INC (ASH) This Year?
by Zacks Equity Research
Here is how Ashland (ASH) and Fortuna Mining (FSM) have performed compared to their sector so far this year.
ArcelorMittal's (MT) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
ArcelorMittal's (MT) second-quarter earnings and sales miss estimates on lower steel shipments and a fall in average selling price.
U.S. Steel's (X) Earnings and Revenues Surpass Estimates in Q2
by Zacks Equity Research
U.S. Steel (X) tops earnings estimates in the second quarter amid pricing headwinds across its segments.
Linde (LIN) Tops Q2 Earnings Estimates
by Zacks Equity Research
Linde (LIN) delivered earnings and revenue surprises of 1.58% and 0.80%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Celanese (CE) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of -15% and 2.74%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Agnico Eagle's (AEM) Q2 Earnings and Sales Beat Estimates
by Zacks Equity Research
Agnico's (AEM) earnings and sales surpassed estimates in the second quarter on higher production and improved gold prices.
Kinross Gold's (KGC) Q2 Earnings and Sales Surpass Estimates
by Zacks Equity Research
Kinross Gold (KGC) earnings and sales surpass estimates in the second quarter on improved gold prices and margins.
FMC's Earnings and Revenues Surpass Estimates in Q2
by Zacks Equity Research
FMC sees improved demand during the second quarter, leading to an increase in sales volumes and the top line.
Albemarle's (ALB) Earnings Miss Estimates in Q2, Revenues Beat
by Zacks Equity Research
While Albemarle (ALB) benefits from higher volumes, lower lithium market pricing weighed on its results in the second quarter.
Ashland (ASH) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Ashland (ASH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
DuPont's (DD) Earnings and Revenues Top Estimates in Q2
by Zacks Equity Research
DuPont's (DD) earnings and sales surpass estimates in the second quarter on increased volumes.
Element's (ESI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Element's (ESI) second-quarter earnings and sales beat estimates on strong growth in the Electronics segment.